Oliver Cornely

‪TDM in hematology...

🔎 209 physicians | 32 countries
✅ 97% access
✅ 71% adapt treatment
⏱ Faster turnaround = more action
🚀 Expanding to targeted therapies
💡 From classical monitoring to precision medicine.
📖 www.mjhid.org/mjhid/articl...

@jannikstemler.bsky.social @olivercornely.bsky.social

YouTube video by IDIM IDIM hMPV in Hematologic Malignancies: Key Insights from EPICOVIDEHA/EPIRESEHA

🎥 New data on #hMPV in patients with hematologic malignancies: @salmantongarcia.bsky.social highlights how the lack of prophylaxis & treatment increases hospitalizations, ICU needs, and mortality.
Watch now: youtu.be/1EsYHcRQZ8g
Publication: doi.org/10.1093/ofid...
#Hematology #InfectiousDiseases

Mycological testing in Australasian clinical mycology laboratories: survey of the current state and access to testing Access to mycological diagnostics varies across clinical laboratories. This study aimed to assess the availability of key fungal diagnostic methods in…

Mycological diagnostics in Australia & NZ vary widely. Key non-culture tests are often offsite, β-D-glucan access is rare, and antifungal resistance surveillance remains limited. Important gaps in regional capability.
🔗 www.sciencedirect.com/science/arti...
#Mycology @salmantongarcia.bsky.social

EQUAL Score Aspergillosis - Apps on Google Play Tool for clinicians and measuring the quality of aspergillosis management

📱 Improve your clinical practice with the EQUAL Score Aspergillosis app! Quantify guideline adherence for pulmonary Aspergillosis treatment. Designed for hospital physicians.
Learn more: equal.uni-koeln.de/aspergillosi... #Aspergillosis #ECMM #ClinicalGuidelines #EQUALScore #MedicalApp

🚨 IATA-Gefahrgutschulung am 25.03.2026 in Köln @zks-koeln.bsky.social ! 🌍 Für den sicheren Versand von humanen Proben & infektiösen Stoffen. Noch wenige Plätze frei! Jetzt anmelden: zks.uni-koeln.de/akademie/iat... #IATA #Gefahrgut #KlinischeForschung

🦠 EHA-SWG Infections in Hematology Webinar
📅 March 2, 2026 | 16:00 CET
🎤 @salmantongarcia.bsky.social
Insights from the EPIAMLINF registry on infections in AML patients – epidemiology, outcomes & clinical impact.
👉 Register now! ehaweb-org.zoom.us/meeting/regi...

Zwei inspirierende Tage bei der Gemeinsamen DZIF/PEG-Jahrestagung 2026 in Bonn! 🧫🌍
Spannende Impulse zu Infektionsforschung, Resistenzen, Innovationen und globalen Herausforderungen. Großer Dank an alle Beteiligten.

#DZIF #PEG #Infektionsforschung #AMR #GlobalHealth #Science

Mycology A-Z - YouTube Mycology A–Z is a multilingual video series that explores the fascinating world of fungi in a concise, accessible, and visually engaging way. The series is d...

We’re excited to host Mycology A–Z as a playlist on our YouTube channel! 🌍🍄
A multilingual video series making mycology accessible for students, professionals & curious minds worldwide. More episodes coming soon!
www.youtube.com/playlist?lis...
#Mycology #Fungi #ScienceCommunication #YoungISHAM

Spannender Vortrag von Laman Rahimli beim DZIF/PEG Meeting 2026: Outcomes invasiver Candida-Infektionen in Europa und den USA – erste Einblicke aus einer laufenden multinationalen Studie (2024–2026). Klinisch hochrelevant!
#Candida #InfectiousDiseases #DZIF #PEG #ClinicalResearch #Mycology

Starker Vortrag gestern von PD Dr. Sibylle C. Mellinghoff zur Dauer des Pneumokokken-Schutzes bei Hämodialysepatient:innen (DOPPIO-Studie) beim gemeinsamen DZIF/PEG-Meeting 2026. Großartige Wissenschaft, echte Relevanz!
#InfectiousDiseases #DZIF #PEG #Vaccination

Heute & morgen: Gemeinsame #DZIF/#PEG-Jahrestagung 2026 in Bonn 🦠🔬
Fokus auf Gender & Precision Medicine, AMR, Drug Development & Wirt-Erreger-Interaktionen.
Unser Team ist heute mit 3 Postern vertreten @salmantongarcia.bsky.social! 💬🖼️
#InfectiousDiseases #AMR #Science

Immer weniger Menschen lassen sich gegen Grippe impfen Die Grippeimpfquote bei über 60-Jährigen ist auf einen Tiefstand seit der Corona-Pandemie gefallen, wie aktuelle Daten der Barmer-Krankenkasse zeigen. Nur 40,8 Prozent wurden 2023 geimpft, weit entfer...

„Dramatisch zu niedrig“ – nur 40,8 % der über 60-Jährigen ließen sich 2023 gegen Grippe impfen. Eine Impfung schützt besonders Ältere und Risikogruppen vor schweren Verläufen. Mehr Infos: www.rnd.de/politik/dram...
#Grippe #Impfung #Gesundheit #Prävention #60plus

Von Schnelltests bis zu Impfstoffen – klinische Studien sichern Gesundheit und retten Leben. Freiwilligen-Register (v-reg) für freiwillige Teilnahme: v-reg.eu

#Medizin #FreiwilligenRegister #Zukunft

Minnesota health officials warn of sexually transmitted fungal infection outbreak

State health officials have identified 13 confirmed and 27 suspected cases of Trichophyton mentagrophytes type VII, a fungal skin infection that causes severe ringworm.

www.cidrap.umn.edu/s...

DGI warnt vor Schwächung der Infektionsmedizin Die DGI warnt vor einer Schwächung der Infektionsmedizin durch eine Streichung der Leistungsgruppe Infektiologie.

⚠️ Die DGI warnt vor einer Schwächung der #Infektiologie.
Neue Daten zeigen: Adipositas erhöht das Risiko für schwere Infektionen deutlich. Infektiologische Expertise rettet Leben, senkt Komplikationen & Kosten – ihre Streichung wäre ein Rückschritt.
👉 biermann-medizin.de/dgi-warnt-vo...

I’m speaking at #ISHAMAsia2026 in Kuala Lumpur (Sept 9–12).
Join leading experts in medical mycology for the latest research and clinical insights.
See you in KL!
isham.asia
#MedicalMycology #ThinkFungus

🦠📊 RKI veröffentlicht erstmals Resistenzdaten zu Pilzen.
Neue ARS-Daten zeigen Resistenzentwicklungen bei Candida spp. und Aspergillus fumigatus in Deutschland. Ein wichtiger Schritt für Therapie & Surveillance.
🔗 amr.rki.de/Content/Date...
#AMR #Pilzresistenzen #RKI

Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) – final report To determine long-term immunogenicity and reactogenicity of different SARS-CoV-2 mRNA-vaccines in a population ≥75 years in a randomized trial.Partici…

Final EU-COVAT-1-AGED results:
Randomized 1st & 2nd mRNA booster trial in adults ≥75 yrs. Full-dose mRNA-1273 showed higher anti-RBD IgG & neutralization vs BNT162b2. Neutralization declined vs all 25 variants at 12 months.
www.sciencedirect.com/science/arti...
#COVID19 #Vaccines #Aging #VACCELERATE

Honored to host Prof. Ruoyu Li & Prof. Yinggai Song at our ECMM Excellence Center Cologne. From Cologne Cathedral to TRIO lab, insightful discussions & guided tours. Looking forward to future collaborations!

At PRISMA Congress, @salmantongarcia.bsky.social presents "The evolving challenge of fungal resistance", highlighting the latest developments and emerging clinical challenges in antifungal resistance. #PRISMA2026 #FungalResistance

YouTube video by IDIM IDIM Rezafungin: A New Echinocandin for Invasive Fungal Infections

🎥 New video!
Prof. @franbridi.bsky.social introduces rezafungin, a next-generation echinocandin, covering MOA, PK profile & clinical potential in invasive fungal infections.
👉 Watch now: youtu.be/4-rKQjsppOg

More videos coming soon!

YouTube video by IDIM IDIM MedFacts with Prof. Schmitt: Adult Vaccination

New episode of MedFacts with Prof. Schmitt 🎥
Clear, science-based insights into adult vaccination, based on the Vaccitutor Course. Short, accessible, and evidence-based vaccine facts.
Watch now ▶️ www.youtube.com/shorts/uTy3t...

Last week’s #READI General Assembly in Madrid ❄️
Dr. Kerstin Albus and Dr. Johanna Brustkern represented WP5 Clinical Sites #Capability Building, strengthening #clinicaltrial site competencies across Europe to support inclusive, multi-centre research. Great energy – READI is in motion 🚀

Mark your calendars for the #AMR Science-Policy Forum at Education Friday during #ESCMIDGlobal2026. Open to all congress attendees, the programme features unique sessions designed to foster interactive, solution-oriented discussions. More info:
https://ow.ly/wIGk50Y60Ml

#IDSky #clinmicro

Honored to feature Prof. Arunaloke Chakrabarti in the ISHAM Pioneers in Mycology series. A deep dive into his impact on medical mycology, global challenges, and the future of fungal disease research. Watch the interview: www.isham.org/about-isham/...

Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer - PubMed Comprehensive literature search and expert panel consensus confirm most of the key recommendations of 2014. New recommendations on the use of G-CSF in immunotherapy settings provide insight and support for day-by-day clinical decision making in the care of patients with cancer.

New AGIHO guideline update on G-CSF prophylaxis in adult cancer patients! Evidence-based recommendations incl. immunotherapy settings, biosimilars & risk stratification to support clinical decision-making.
🔗 pubmed.ncbi.nlm.nih.gov/41570611/
@rosannesprute.bsky.social
#Oncology #Guidelines

Room 007. I can hear Gladys Knight singing License to Kill ... Fungi. Always wanted to know who 006 and 008 are - we’ll find out. Meanwhile in Leuven: ESCMID Antifungal Stewardship, led by Riina Richardson.
👉 www.escmid.org/education/co...

Repetitorium Internistische Intensivmedizin In diesem Werk findet sich das gesamte Spektrum der internistischen Intensivmedizin systematisch, leitlinienorientiert und praxisnah dargestellt.

Die 4. Auflage von „Internistische Intensivmedizin“ ist da: systematisch, leitlinienorientiert und praxisnah – ideal für Klinikalltag und Prüfungsvorbereitung.
📖 Mehr hier: link.springer.com/book/10.1007...
#Intensivmedizin #Klinik #Medizin

Kerstin Albus & Johanna Brustkern from our Cologne team are in Madrid ❄️ for Day 1 of the #READI General Assembly – driving clinical research that truly reflects all populations and promotes equity, diversity, and inclusion.
#READI #GlobalHealth #HealthEquity #ImplementationScience